Press Releases

ERBELLA Showcases Liquid PLLA and Cross-linked HA Innovation on the Middle Eastern Aesthetic Stage

Writer USCarePharm

2025-11-11

Targeting the Middle East K-Medical Market with Natural Volume and Personalized Skin Boosters

The medical aesthetics brand ERBELLA participated in Beautyworld Middle East 2025, held from October 27–29 at the Dubai World Trade Centre, presenting its signature product ERBELLA AQ along with an eight-product skin booster lineup that captured the attention of professionals across the Middle Eastern beauty and medical aesthetics industry.

Beautyworld Middle East is the largest beauty and cosmetics exhibition in the region, featuring over 60 countries and hundreds of global brands each year. The 2025 edition highlighted cutting-edge innovations in K-beauty, skincare, medical aesthetics, and medical devices, with Korean brands earning strong recognition for their advanced technologies and product competitiveness in the Middle Eastern market.

At its booth, ERBELLA introduced its innovative liquid-type PLLA filler “ERBELLA AQ” to major buyers and medical professionals from Dubai, Saudi Arabia, Qatar, and other regions, emphasizing its combination of natural volume and exceptional safety as key differentiators.

ERBELLA AQ features a ready-to-use liquid formulation that combines Poly-L-lactic acid (PLLA) with cross-linked hyaluronic acid (HA), eliminating the need for a separate reconstitution process.
This user-friendly formula enhances treatment convenience for practitioners while delivering instant hydration and volume upon injection. The cross-linked HA provides immediate plumping and moisture, while PLLA gradually stimulates collagen synthesis for long-lasting and natural volume improvement over time.

Its stable liquid format minimizes the risk of nodules or granuloma formation, offering a high level of safety that meets the strict quality and stability standards of the Middle Eastern aesthetic market — a key reason why the product drew strong interest from local buyers.

Beyond the AQ filler, ERBELLA also unveiled an eight-type skin booster lineup targeting specific skin needs such as firmness, antioxidant protection, and regeneration.
Each formulation is designed for customized combination treatments depending on skin condition and procedure goals, positioning ERBELLA as a premium aesthetic brand suited for the step-by-step skincare programs favored in the Middle East.

An ERBELLA representative commented,

“ERBELLA AQ is more than a collagen stimulator — it’s a liquid PLLA solution that delivers natural, long-lasting volume. Our skin booster lineup further represents our identity as a total aesthetic care brand focused on comprehensive skin health and beauty.”

“Through this exhibition, we aim to redefine the standards of K-Medical technology and beauty across the Middle East and the global market.”

The Middle East has recently emerged as one of the fastest-growing regions in the aesthetic and cosmetic medical industry, with soaring demand for K-beauty and K-medical products.
Building on successful partnerships and distribution agreements in Saudi Arabia and Iraq, ERBELLA is accelerating its expansion throughout the region. Following its participation in Beautyworld Middle East, the brand plans to further strengthen local partnerships and distribution networks to solidify its market presence.

Source: E-Donga (https://edu.donga.com)

관련자료

개인정보 수집 및 이용동의

  • 1. 개인정보 수집 및 이용 주체

    -

  • 2. 개인정보 수집 및 이용 목적

    -

  • 3. 개인정보 수집 및 이용 항목

    -

  • 4. 개인정보 보유 및 이용기간

    -

  • 5. 동의를 거부할 권리 및 동의를 거부할 경우의 불이익